By Paul A. Harris
Portland, Ore., July 19 - Hologic Inc. priced an upsized $1 billion issue of eight-year senior notes (B2/BB/) at par to yield 6¼% on Thursday, according to market sources.
The yield printed at the tight end of yield talk that had been set in the 6 3/8% area.
Goldman Sachs & Co. ran the books for the issue, which was upsized from $750 million.
The Bedford, Mass.-based medical diagnostic systems developer and manufacturer plans to use the proceeds to help fund the acquisition of Gen-Probe Inc.
| Issuer: | Hologic Inc.
|
| Amount: | $1 billion, increased from $750 million
|
| Maturity: | Aug. 1, 2020
|
| Securities: | Senior notes
|
| Bookrunner: | Goldman Sachs & Co.
|
| Coupon: | 6¼%
|
| Price: | Par
|
| Yield: | 6¼%
|
| Call protection: | Make-whole call at Treasuries plus 50 bps for the first three years, then callable at a premium
|
| Trade date: | July 19
|
| Settlement date: | Aug. 1
|
| Ratings: | Moody's: B2
|
| Standard & Poor's: BB
|
| Distribution: | Rule 144A and Regulation S with registration rights
|
| Price talk: | 6 3/8% area
|
| Marketing: | Roadshow
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
